Consensus Statement on Use of Ambulatory Glucose Profile in Patients with Type 2 Diabetes Mellitus Receiving Oral Antidiabetic Drugs

摘要

Glucose monitoring is an important aspect of diabetes care. The traditionalmethodologies of blood glucose monitoring such as fasting plasma glucose,post prandial glucose, glycosylated hemoglobin and self-monitoring of bloodglucose do not adequately address hypoglycemia and glycemic variability, whichare two important risk factors for diabetes-related complications. Ambulatoryglucose profile (AGP) developed from a continuous glucose monitoring systemis a simplified report, with standardized statistics and targets and visualrepresentation of time in standardized glycemic ranges, glucose variability, andglycemic exposure over a single 24-h day. The role of AGP in T2DM patients whoare on oral anti-diabetic drugs (OADs) is still not clearly defined. An expert groupof endocrinologists and diabetologists met in Pune, India to discuss the role ofAGP in T2DM patients on OADs. This article aims to discuss the consensus of theexpert group on the role of AGP in T2DM patients on OADs and also reviews thevarious aspects of AGP and its interpretation; and the available evidences fordisease management including treatment options based on AGP report.